209 related articles for article (PubMed ID: 33374096)
1. Basal Serum Thyroxine Level should Guide Initial Thyroxine Replacement Dose in Neonates with Congenital Hypothyroidism.
Günbey C; Özön A; Gönç EN; Alikaşifoğlu A; Karahan S; Kandemir N
J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):269-275. PubMed ID: 33374096
[TBL] [Abstract][Full Text] [Related]
2. Does initial dosing of levothyroxine in infants with congenital hypothyroidism lead to frequent dose adjustments secondary to iatrogenic hyperthyroidism on follow-up?
Craven M; Frank GR
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):597-600. PubMed ID: 29715192
[TBL] [Abstract][Full Text] [Related]
3. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
Salerno M; Militerni R; Bravaccio C; Micillo M; Capalbo D; Di MS; Tenore A
Thyroid; 2002 Jan; 12(1):45-52. PubMed ID: 11838730
[TBL] [Abstract][Full Text] [Related]
4. Validity of Six Month L-Thyroxine Dose for Differentiation of Transient or Permanent Congenital Hypothyroidism.
Asena M; Demiral M; Unal E; Öcal M; Demirbilek H; Özbek MN
J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):275-280. PubMed ID: 31990163
[TBL] [Abstract][Full Text] [Related]
5. Levothyroxine replacement in primary congenital hypothyroidism: the higher the initial dose the higher the rate of overtreatment.
Tuhan H; Abaci A; Cicek G; Anik A; Catli G; Demir K; Bober E
J Pediatr Endocrinol Metab; 2016 Feb; 29(2):133-8. PubMed ID: 26244672
[TBL] [Abstract][Full Text] [Related]
6. Iatrogenic hyperthyroidism in primary congenital hypothyroidism: prevalence and predictive factors.
Chooprasertsuk N; Dejkhamron P; Unachak K; Wejaphikul K
J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1250-1256. PubMed ID: 36100363
[TBL] [Abstract][Full Text] [Related]
7. Mean High-Dose l-Thyroxine Treatment Is Efficient and Safe to Achieve a Normal IQ in Young Adult Patients With Congenital Hypothyroidism.
Aleksander PE; Brückner-Spieler M; Stoehr AM; Lankes E; Kühnen P; Schnabel D; Ernert A; Stäblein W; Craig ME; Blankenstein O; Grüters A; Krude H
J Clin Endocrinol Metab; 2018 Apr; 103(4):1459-1469. PubMed ID: 29325045
[TBL] [Abstract][Full Text] [Related]
8. Levothyroxine Dosage as Predictor of Permanent and Transient Congenital Hypothyroidism: A Multicenter Retrospective Study in Japan.
Itonaga T; Higuchi S; Shimura K; Nagasaki K; Satoh M; Takubo N; Takahashi I; Sawada H; Hasegawa Y
Horm Res Paediatr; 2019; 92(1):45-51. PubMed ID: 31553976
[TBL] [Abstract][Full Text] [Related]
9. Plasma free fatty acids in neonates with congenital hypothyroidism.
Asami T; Wada M; Uchiyama M
Thyroid; 2001 Jan; 11(1):81-4. PubMed ID: 11272101
[TBL] [Abstract][Full Text] [Related]
10. A novel therapeutic paradigm to treat congenital hypothyroidism.
Mathai S; Cutfield WS; Gunn AJ; Webster D; Jefferies C; Robinson E; Hofman P
Clin Endocrinol (Oxf); 2008 Jul; 69(1):142-7. PubMed ID: 18598275
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Congenital Hypothyroidism: Impact of Secular Changes in Levothyroxine Initial Dose on Early Growth.
Niuro L; Danner E; Viikari L; Kero J; Huopio H; Jääskeläinen J; Niinikoski H
Horm Res Paediatr; 2023; 96(4):376-384. PubMed ID: 36476603
[TBL] [Abstract][Full Text] [Related]
12. Etiological, clinical, and laboratory evaluation of congenital hypothyroidism and determination of levothyroxine (LT4) dose at treatment interruption in differentiating permanent vs. transient patients.
Dündar İ; Büyükavcı MA; Çiftçi N
Turk J Med Sci; 2022 Dec; 52(6):1863-1871. PubMed ID: 36945978
[TBL] [Abstract][Full Text] [Related]
13. A novel useful marker in the early discrimination of transient hyperthyrotropinemia/hypothyroxinemia and congenital hypothyroidism in preterm infants: thyroid-stimulating hormone/free thyroxine ratio.
Cakir U; Tayman C
J Pediatr Endocrinol Metab; 2024 Jun; 37(6):536-542. PubMed ID: 38662611
[TBL] [Abstract][Full Text] [Related]
14. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
15. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
Bagattini B; Cosmo CD; Montanelli L; Piaggi P; Ciampi M; Agretti P; Marco GD; Vitti P; Tonacchera M
Eur J Endocrinol; 2014 Nov; 171(5):615-21. PubMed ID: 25305309
[TBL] [Abstract][Full Text] [Related]
16. Liothyronine Improves Biochemical Control of Congenital Hypothyroidism in Patients with Central Resistance to Thyroid Hormone.
Paone L; Fleisch AF; Feldman HA; Brown RS; Wassner AJ
J Pediatr; 2016 Aug; 175():167-172.e1. PubMed ID: 27178621
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cognitive and motor development in toddlers with congenital hypothyroidism diagnosed by neonatal screening.
van der Sluijs Veer L; Kempers MJ; Wiedijk BM; Last BF; Grootenhuis MA; Vulsma T
J Dev Behav Pediatr; 2012 Oct; 33(8):633-40. PubMed ID: 23027136
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of transient hypothyroidism in patients diagnosed with congenital hypothyroidism.
Peltek Kendirci HN; Aycan Z; Sağsak E; Keskin M; Çetinkaya S
Turk J Med Sci; 2015; 45(4):745-50. PubMed ID: 26422840
[TBL] [Abstract][Full Text] [Related]
19. The severity of congenital hypothyroidism of central origin should not be underestimated.
Zwaveling-Soonawala N; van Trotsenburg AS; Verkerk PH
J Clin Endocrinol Metab; 2015 Feb; 100(2):E297-300. PubMed ID: 25347570
[TBL] [Abstract][Full Text] [Related]
20. Three-year follow-up of children with abnormal newborn screening results for congenital hypothyroidism.
Kang MJ; Chung HR; Oh YJ; Shim YS; Yang S; Hwang IT
Pediatr Neonatol; 2017 Oct; 58(5):442-448. PubMed ID: 28412200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
